Glenmark Pharma shares hit 52-week low as global brokerages cut target after weak Q1
Updated : August 16, 2019 12:45 PM IST
Shares of Glenmark Pharma fell 6 percent to its 52-week low of Rs 360.35 on Friday on poor June quarter results.
The sentiment was further affected as global brokerages cut their 12-month target price for the stock post the earnings.
Glenmark Pharma reported a 53 percent year-on-year (YoY) fall in its consolidated net profit at Rs 109.28 crore as against Rs 233 crore a year ago.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more